Discover other news

Positive results of research treatment-resistant depression

Suffering from depression that does not respond to existing treatments is obviously one of the most profoundly human diseases.

As one of the world experts on depression, our principal investigator and CEO Dr. Erik Buntinx, psychiatrist, has been researching new treatments for depression, including esketamine, for decades.

This research has very recently led to a new breakthrough, published by the pharmaceutical company Janssen:

More research into the effects of esketamine as well as other innovative drugs in depression is currently being conducted at Anima under the direction of Dr. Erik Buntinx in collaboration with Jessa, among others. You can always apply for this:

Subscribe to our quarterly newsletter and stay informed about new studies and developments.